The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

MILBEMAX tablets for small dogs and puppies

Elanco GmbHVPA22020/008/001

Main Information

Trade NameMILBEMAX tablets for small dogs and puppies
Active SubstancesMilbemycin oxime
Dosage FormTablet
Licence HolderElanco GmbH
Licence NumberVPA22020/008/001

Group Information

ATC CodeQP54AB51 milbemycin oxime, combinations
Therapeutic ClassEndoparasiticide


License statusAuthorised
Licence Issued22/04/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back